Lee’s Pharmaceutical Holdings Limited (HK:0950) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Lee’s Pharmaceutical Holdings Limited has announced an expected unaudited net profit of HK$58 million to HK$63 million for the first half of 2024, a significant increase from the HK$16 million in the same period in 2023. This positive financial turnaround is attributed to increased sales from products on the National Reimbursement Drug List, reduced research and development costs, and effective management cost-saving initiatives. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares.
For further insights into HK:0950 stock, check out TipRanks’ Stock Analysis page.